Breaking News

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

Implements a multi-step action plan to ensure regulatory alignment with the latest NDSRI guidelines.

Author Image

By: Charlie Sternberg

Associate Editor

Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has achieved regulatory compliance for nitrosamine impurities by implementing a multi-step action plan to ensure regulatory alignment with the latest NDSRI guidelines. The first step of this proactive approach involved the development of a cross-functional core team comprised of subject matter experts from Regulatory Affairs, Central Quality, R&D, and Manufacturin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters